Omeprazol Sandoz (Omeprazole)

Omeprazol Sandoz is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.
• Helicobacter pylori eradication regimens: used as part of triple‑therapy to improve eradication rates.
• NSAID‑associated ulcer prophylaxis: lowers the risk of ulcer development in patients requiring long‑term NSAID therapy.

• Omeprazole irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells, inhibiting the final step of acid secretion. By blocking this pump, it markedly reduces gastric acidity, allowing mucosal healing and providing symptom relief in acid‑related disorders.

Omeprazol Sandoz is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea or abdominal discomfort.
• Flatulence or bloating.
• Constipation: occasional.
• Dry mouth.

Serious or Rare Side Effects

• Severe allergic reactions (anaphylaxis, angioedema).
• Clostridioides difficile‑associated colitis.
• Low magnesium levels (hypomagnesemia) with prolonged use.
• Bone fracture risk with long‑term high‑dose therapy.
• Acute interstitial nephritis.
• Liver enzyme abnormalities.

Before starting Omeprazol Sandoz, consider the following precautions:

• Assess renal and hepatic function: dose adjustment may be needed in severe impairment.
• Review long‑term use: prolonged therapy may increase risk of fractures, infections, and nutrient deficiencies.
• Monitor for drug interactions: especially with antiplatelet agents, warfarin, and HIV protease inhibitors.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation.
• Pediatric use: safety and efficacy established for specific age groups; follow prescribing information.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazol Sandoz can affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, consider alternative therapy.
• Atazanavir or other protease inhibitors: markedly decreased antiviral exposure.
• Methotrexate (high dose): increased toxicity risk.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR, monitor coagulation parameters.
• Digoxin: may increase serum levels, observe for toxicity signs.
• Phenytoin: reduced clearance, monitor seizure control.
• Iron supplements: decreased absorption, separate dosing by at least 2 hours.